跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
MELATONINA AUROVITAS 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
MELATONINA AUROVITAS 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 5, 2021
Approval ID
5be6c43a5426f30c
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
5be6c43a5426f30c
Drug Cima Aemps Name
MELATONINA AUROVITAS 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86265
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2021-10-05
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
2 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
MELATONINA
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 5, 2021
Approval ID
5be6c43a5426f30c
Type
Standard
Back to CIMA-AEMPS Approvals
MELATONINA AUROVITAS 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details